GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Xiamen Amoytop Biotech Co Ltd (SHSE:688278) » Definitions » Additional Paid-In Capital

Xiamen Amoytop Biotech Co (SHSE:688278) Additional Paid-In Capital : ¥0 Mil(As of Mar. 2025)


View and export this data going back to 2020. Start your Free Trial

What is Xiamen Amoytop Biotech Co Additional Paid-In Capital?


Xiamen Amoytop Biotech Co's quarterly additional paid-in capital increased from Sep. 2024 (¥0 Mil) to Dec. 2024 (¥397 Mil) but then stayed the same from Dec. 2024 (¥397 Mil) to Mar. 2025 (¥0 Mil).

Xiamen Amoytop Biotech Co's annual additional paid-in capital stayed the same from Dec. 2022 (¥397 Mil) to Dec. 2023 (¥397 Mil) and stayed the same from Dec. 2023 (¥397 Mil) to Dec. 2024 (¥397 Mil).


Xiamen Amoytop Biotech Co Additional Paid-In Capital Historical Data

The historical data trend for Xiamen Amoytop Biotech Co's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xiamen Amoytop Biotech Co Additional Paid-In Capital Chart

Xiamen Amoytop Biotech Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only 396.54 396.54 396.54 396.54 396.54

Xiamen Amoytop Biotech Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 396.54 - 396.54 -

Xiamen Amoytop Biotech Co Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Xiamen Amoytop Biotech Co Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Xiamen Amoytop Biotech Co's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Xiamen Amoytop Biotech Co Business Description

Traded in Other Exchanges
N/A
Address
No.330 Wengjiao Road, Xinyang Industry Zone of Haicang, Fujian, Xiamen, CHN, 361022
Xiamen Amoytop Biotech Co Ltd operates as a drug development company. The Company develops and sells protein drugs, interferon drugs, and other products.
Executives
Lan Chun Director
Wang Jun Ye Director

Xiamen Amoytop Biotech Co Headlines

No Headlines